-
Nov 24, 2024 | 00417-0/abstract&sz=64)
arthroplastyjournal.org | Roberta E. Redfern |Zimmer Biomet |Ari Seidenstein |Omar A. Sarhan
Keywordsmobile healthstairsstep countstotal hip arthroplastyanterior approachposterior approachGet full text accessLog in, subscribe or purchase for full access. References1. Dailiana, Z.H. ∙ Papakostidou, I. ∙ Varitimidis, S. ... Patient-reported quality of life after primary major joint arthroplasty: a prospective comparison of hip and knee arthroplastyBMC Musculoskelet Disord. 2015; 16:3662. Rissanen, P. ∙ Aro, S. ∙ Sintonen, H. ...
-
Nov 13, 2024 | 
wgntv.com | Zimmer Biomet
Schwarzenegger to Inspire a Bold New Era of Well-being, Active Living and Reinvention to Advance Company's Mission to Alleviate Pain and Improve the Quality of Life for People Around the WorldWARSAW, Ind., Nov. 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced a partnership with Arnold Schwarzenegger, who will take on the newly established role of Chief Movement Officer.
-
Nov 13, 2024 | 
news-journal.com | Zimmer Biomet
Schwarzenegger to Inspire a Bold New Era of Well-being, Active Living and Reinvention to Advance Company's Mission to Alleviate Pain and Improve the Quality of Life for People Around the World
-
Oct 20, 2024 | 
epicos.com | Zimmer Biomet |Lean as
Oct 20, 2024 SOURCE: PR NewsWire -- Kingdom of Saudi Arabia opens the Global Health Exhibition (21-23 October 2024) tomorrow, a major international healthcare event with 100,000+ health and patient care stakeholders in attendance alongside over 1,200 exhibiting companies and brands, including Abbott, Baxter, Siemens, Zimmer Biomet, Johnson & Johnson and many more -- Exhibition features over 500 expert speakers across five healthcare disciplines, introducing frontier-pushing medical technology...
-
May 28, 2024 | 
kr.investing.com | Zimmer Biomet
화요일, TD Cowen은 일관된 목표 가격 인 $ 143.00과 함께 Zimmer Biomet (NYSE:ZBH)의 주식에 대해 보류 등급을 유지했습니다. 이 회사의 입장은 5월 29일로 예정된 의료 기기 회사의 투자자의 날을 앞두고 나온 것입니다. TD Cowen이 Zimmer Biomet의 투자의견을 보류로 유지하기로 결정한 것은 페르소나 IQ와 오세오티 시멘트리스 등 이 회사의 최신 제품에 익숙한 정형외과 의사와의 대화에 따른 것입니다. 이러한 혁신은 짐머 바이오메드의 매출 성장을 견인할 잠재력이 있는 것으로 여겨집니다. TD 코웬은 짐머 바이오메드가 다가오는 투자자의 날에 이러한 신제품의 기여에 대한 보다 자세한 전망을 제공할 것으로 예상하고 있습니다. 페르소나 IQ와 오세오티 시멘트리스의 향후 매출 성장에 대한 회사의 확신은 이러한 기기를 직접 사용해 본 의료 전문가의 통찰력을 통해 더욱 강화되었습니다.
-
May 21, 2024 | 
openpr.com | Zimmer Biomet
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to ๐๐๐, the global Medical Biomedical Materials 3.0 Market size in terms of revenue was valued at around USD XX.X billion in 2023 and is expected to reach a value of ๐๐๐ ๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, growing at a ๐๐๐๐ ๐จ๐ ๐ซ๐จ๐ฎ๐ ๐ก๐ฅ๐ฒ ๐๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
-
Feb 1, 2024 | 
uk.investing.com | Zimmer Biomet
© Reuters. Blackstone, Zimmer Biomet And A Membership Warehouse Retailer: CNBC's 'Final Trades'Benzinga - by Avi Kapoor, Benzinga Staff Writer. On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes Blackstone Inc. (NYSE: BX) here, despite the firm's mixed fourth-quarter 2023 results. The company reported adjusted revenues of $2.54 billion, missing the consensus of $2.57 billion. Distributable earnings (DE) rose 4% Y/Y to $1.39 billion.
-
Dec 4, 2023 | 
jamanetwork.com | Jose-Miguel Yamal |Mikala C. Osani |Zimmer Biomet |Journey Martinez
Key PointsQuestion Is there a difference in the long-term risk of mortality and morbidity outcomes for adults with hypertension starting 1 of 3 antihypertensive treatments: thiazide-type diuretic, calcium channel blocker, or angiotensin-converting enzyme (ACE) inhibitor?
-
Oct 18, 2023 | 
trialbulletin.com | Zimmer Biomet
OverviewA prospective multicenter longitudinal cohort study of Zimmer Biomet (ZB) Persona IQ The
Smart Knee which consists of the Persona Personalized Knee (PPK) System with mymobility®
platform that is attempting to develop correlative measures to assist surgeons in
understanding and managing risk in their patient populations.
-
Sep 6, 2023 | 
en.prnasia.com | Zimmer Biomet
นิวเดลี—6 ก.ย. 2566—พีอาร์นิวส์ไวร์/ดาต้าเซ็ต ซิมเมอร์ ไบโอเมท อินเดีย (Zimmer Biomet India) ประกาศเปิดตัวแคมเปญซิมเมอร์ ไบโอเมท ออน วีลส์ (Zimmer Biomet on Wheels) โดยเป็นยานพาหนะเคลื่อนที่ มาพร้อมผลิตภัณฑ์และโซลูชันสุดล้ำของบริษัทฯ ทั้งกลุ่มผลิตภัณฑ์สำหรับข้อเข่า สะโพก ไหล่ และเวชศาสตร์การกีฬา ซึ่งใช้ประโยชน์จากข้อมูล การวิเคราะห์ และปัญญาประดิษฐ์ แคมเปญนี้นำเทคโนโลยีที่เป็นนวัตกรรมและเฉพาะบุคคลของซิมเมอร์ ไบโอเมท มาใช้ประโยชน์...
